Multiple sclerosis (MS) shows one of the stronger observational links to vitamin D. Higher levels associate with reduced risk of developing MS, and lower levels correlate with increased disease activity, relapses, or MRI changes in those diagnosed. Genetic studies (Mendelian randomization) support a causal role, suggesting low vitamin D contributes to higher MS susceptibility.
Some trials indicate high-dose supplementation may reduce disease activity in early or clinically isolated syndrome cases (e.g., fewer relapses or lesions). However, results vary, and not all studies confirm broad benefits for established MS. While promising for risk reduction, supplementation’s role in treatment remains under investigation.
Vitamin D and Certain Types of C//ncerObservational studies frequently link higher vitamin D levels to lower risks for specific cancers, such as colorectal (strongest association), and possibly bladder or others. Some analyses show reduced cancer mortality (e.g., 13% lower in certain meta-analyses of trials).
Randomized trials, however, often find no overall reduction in cancer incidence from supplementation. A few report benefits in secondary outcomes, like lower advanced cancer risk (e.g., metastatic or fatal cases, particularly in normal-weight individuals). Evidence is mixed—no consistent proof that supplements prevent cancer broadly, though maintaining adequate levels supports general health.
Actionable Tips to Support Healthy Vitamin D Levels
Here are practical steps to consider:
Get safe sun exposure: Aim for midday sunlight on arms a
